Biotech · Public company · Dallas, TX, US
Instil Bio, Inc.
Ticker TIL · SEC CIK 0001789769
Track this companyFree. Adds Instil Bio, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline2
- ITIL-168Phase 2 · Advanced Cutaneous MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- ITIL-306Phase 1 · Epithelial Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid TumorsPHASE1 · TERMINATED · started Sep 15, 2025ClinicalTrials.gov NCT07159828 · fetched Nov 12, 2026
- ITIL-306 in Advanced Solid TumorsPHASE1 · TERMINATED · started Aug 24, 2022ClinicalTrials.gov NCT05397093 · fetched Nov 12, 2026
- ITIL-168 in Advanced MelanomaPHASE2 · TERMINATED · started Oct 7, 2021ClinicalTrials.gov NCT05050006 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Aug 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 11, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 15, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 15, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 3, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 27, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 27, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jan 6, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 13, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 13, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 13, 2025 · fetched Nov 12, 2026